 |
BioWorld-Insight-2002-04-29
ESO Accounting Changes Could Hurt Biotech Hiring, Bottom Lines
ESO Accounting Changes Could Hurt Biotech Hiring, Bottom Lines
As if implications of the Enron Corp. situation hadn't already messed things up enough for biotechnology (and just about every other sector that uses balance sheets and ledgers), another spawn of the scandal has reared its head for industry leaders to fear and loathe. (BioWorld Financial Watch)